Login with your work email address to view charts. No credit card required.
| Art Unit: | 1638 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1630 — Stem cells and cell culture and Nucleic Acid related therapy |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 424 — Drug, bio-affecting and body treating compositions 536 — Organic compounds -- part of the class 532-570 series 435 — Chemistry: molecular biology and microbiology 504 — Plant protecting and regulating compositions 800 — Multicellular living organisms and unmodified parts thereof and related processes 436 — Chemistry: analytical and immunological testing |
| Phone: | (571) 272-2914 |
| Email: | None |
| Location: | None |
| Title: | Supvy Pat Examnr Biolgy |
| Service: | 22 years |
| Grade: | GS-15 |
| 3-Year Grant rate: | 83% over 274 cases |
|---|---|
| Difficulty: | Easier |
| Difficulty Percentile: | 37th
|
With Examiner Vivlemore (SPE), you have a 83% chance of getting an issued patent by 3 years after the first office action. Examiner Vivlemore (SPE) is an easier examiner and in the 37th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Vivlemore (SPE), where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Vivlemore (SPE)'s grant rate is higher than that of Art Unit 1638 and higher than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Vivlemore (SPE) | 1.1 |
| Art Unit 1638 | 2.1 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.